US Stock MarketDetailed Quotes

VTVT vTv Therapeutics

Watchlist
  • 25.9900
  • -0.8400-3.13%
Close May 10 16:00 ET
  • 25.4800
  • -0.5100-1.96%
Post 16:01 ET
63.23MMarket Cap-2980P/E (TTM)

About vTv Therapeutics Company

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.

Company Profile

SymbolVTVT
Company NamevTv Therapeutics
Listing DateJul 30, 2015
Issue Price15.00
Founded2015
CEOMr. Paul J. Sekhri
MarketNASDAQ
Employees16
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3980 Premier Drive,Suite 310
CityHigh Point
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27265
Phone1-336-841-0300
Websitehttp://www.vtvtherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul J. Sekhri
  • Chairman of the Board, President and Chief Executive Officer
  • 650.91K
  • Steven L. Tuch
  • Executive Vice President and Chief Financial Officer
  • 465.25K
  • Richard S. Nelson
  • Director and Executive Vice President, Corporate Development
  • --
  • Dr. Jonathan Isaacsohn
  • Executive Chairman of the Board
  • --
  • Hersh Kozlov
  • Director
  • 100.13K
  • Daniel K. Spiegelman
  • Director
  • --
  • Dr. Srinivas Akkaraju
  • Director
  • --
  • Dr. Raymond Cheong, PhD
  • Director
  • --
  • Dr. Keith Harris
  • Independent Director
  • 107.63K
  • Fahed Al-Marzooqi
  • Independent Director
  • 87.63K
  • Dr. Anne M. Phillips, M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg